Shield Therapeutics (STX.L) traded flat 0 % during a 24 hours period ending at 06:35 AM Central Europe on Thursday 29th. One Shield Therapeutics stock can currently be bought for about GBX 5.45 on popular exchanges. Current supply of Shield Therapeutics stocks is 1.1 bn. Shield Therapeutics has a current market capitalization of GBX 77.9 mn and approximately GBX 264.1 k worth of Shield Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Shield Therapeutics has traded -2.68 % down. Simple moving average of last 200 days is at GBX 7.06. The highest price of past 52 weeks was recorded at GBX 12.5 on 01/16/2026. 52 weeks low was at GBX 3.7 on 08/07/2026.

Here is how related stocks have performed in the past 24 hours:

  • Michelmersh Brick P (MBH.L) traded down -0.98 % and now trades at GBX 70.5. Current market capitalisation for Michelmersh Brick P is GBX 85.7 mn. Current price/earnings ratio for Michelmersh Brick P is 17.29.

  • Zephyr Energy (ZPHR.L) traded up 1.61 % and now trades at GBX 3.15. Current market capitalisation for Zephyr Energy is GBX 86.8 mn. Zephyr Energy has a current price to earnings ratio of 21.16.

  • Activeops (AOM.L) traded flat 0 % and now trades at GBX 97.5. Current market capitalisation for Activeops is GBX 93.1 mn.

  • Jubilee Metals (JLP.L) traded up 2.5 % and now trades at GBX 2.05. Current market capitalisation for Jubilee Metals is GBX 87.7 mn.

  • Kooth (KOO.L) traded flat 0 % and now trades at GBX 189.5. Kooth has a market capitalisation of GBX 91.5 mn. Current price/earnings ratio for Kooth is 11.32.

About Shield Therapeutics

Shield Therapeutics PLC is a specialty pharmaceutical company from the United Kingdom, which has its main base in Gateshead. The company’s sector of operation is Health Care and its primary industry is Pharmaceuticals. Their mission revolves around the development and commercialization of secondary care-focused pharmaceuticals. The key late-stage products of Shield Therapeutics include an innovative oral medication for the treatment of iron deficiency anemia and an iron-based phosphate binder for addressing hyperphosphatemia issues. You can find more information about this company and its offerings on their official website, which is www.shieldtherapeutics.com . They are listed on the London Stock Exchange.